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August 2013 5000 IU of Heparin before clamping of the carotid arteries. Blood was drawn from fasting individuals within 14 days before CEA. Homocysteine was measured with an AxSYMPlusImmunologyanalyzer (Abbott Diagnostics, IL).
Statistical Analysis
The effect of tHcy on survival was estimated in a multivariate proportional hazard model (Cox Regression), including cardiovascular risk factors (Table 1) , which were used for computation of prognostic indices (PI) 6 for the primary end point. PIs equal the sum of the product of mean-centered covariate values and their corresponding parameter estimates for each case. 6 The discriminative ability of the PI was determined by the ROC-Curves (area under the curve [AUC]), calibration by Hosmer-Lemeshow test (goodness-of-fit). The stratification power of PI-quintiles over time was estimated by Kaplan-Meier curves. A 2-sided P value of <0.05 was considered to indicate statistical significance.
Outcomes
The primary outcome of this study was defined as death of any cause within 5 years after CEA.
Results
Demographic data of 214 patients are described in Table 1 After removal of nonsignificant effects from the multivariate regression model, the variables homocysteine, age, smoking, and sex emerged as significant variables and were used for the computation of a prognostic model for 5-year postoperative survival yielding PIs. 6 The discriminative ability of age rendered an AUC of 0.69±0.04. This was significantly increased, when the effect of tHcy was added to age (AUC of 0.74±0.04). The Hosmer-Lemeshow test indicated good calibration (χ 2 =4.47; P=0.813). PI-based quintiles showed a good stratification of the survival estimate of the patients (P<0.0001), as illustrated in the Figure. Within 5 years, each increment of PI was associated with a higher cardiac risk (HR=3.25; 95% CI, 2.0-5.2; P<0.001) than stroke (any) risk (HR=1.86; 95% CI, 1.1-3.2; P=0.023). After adjustment for risk factors, postoperative stroke risk remained significantly higher in patients with high tHcy levels (HR=2.75; 95% CI, 1.1-6.7; P=0.025) or PI despite performed CEA. Finally, to assess the effect (reclassification) of our prognostic model for 5 years, we estimated the percentage distribution of age groups over the quintiles of PIs, as shown in 
Discussion
A PI including tHcy, as well as age, showed a better risk stratification in patients undergoing surgery for their ACAS than age alone. Our prognostic model for 5 years postoperative survival performs better than currently used clinical indices, like the CHADS2 (Congestive Heart failure, Hypertension, Age >75 years, Diabetes mellitus, prior Stroke, or transient ischemic attack) index (AUC, 0.68-0.72) 7 and even improved for prediction of long-term survival (8.5 years; AUC, 0.8±0.03). Furthermore, with each increment of tHcy or PI, the risk of cardiac death, thereby limiting the benefit from CEA, increases even more than stroke risk. Additionally, the increased stroke risk predicted by high compared with low tHcy levels is likely to remain highly significant despite performed CEA, further 
Limitations
This study lacks a control group with high-grade ACAS not undergoing CEA, in which adverse events are correlated to homocysteine levels.
Conclusions
Inclusion of the cardiovascular biomarker homocysteine allows a better risk stratification of postoperative survival in elderly patients than by age alone. Given their increased risk of cardiac death, because tHcy-related and not ACAS-related cardiac risk increases more than stroke risk, the need for CEA in hyperhomocysteinemic patients with ACAS should be carefully considered, prompting intensive medical therapy rather than CEA as adequate treatment. The version of the article, "Homocysteine Improves Risk Stratification in Patients Undergoing Endarterectomy for Asymptomatic Internal Carotid Artery Stenosis" by Duschek et al that published online ahead-of-print on June 11, 2013, and appears in the August issue (Stroke. 2013;44:2311-2314) contained an error in the text.
In accordance with the STROBE criteria, 1,2 the study has been reclassified as a single-center cohort study, as its participants were sampled on the basis of exposure and the outcome was assessed during follow-up.
